Pseudogene similar to a hypothetical protein (no established HGNC-approved canonical full name; pseudogenes are typically named with reference to their parental gene, but here none is specified[2]) (ENSG00000228687 (Ensembl identifier; no common gene symbol or abbreviation[2]))

Pseudogenes are DNA sequences that closely resemble functional genes but have acquired mutations (such as stop codons or frameshifts) that prevent them from producing functional proteins[2][3]. Most pseudogenes, including ENSG00000228687, are considered nonfunctional, though some may be transcribed and exert regulatory influence at RNA level[1][3]. "Pseudogene similar to a hypothetical protein" refers to its homology to an uncharacterized or hypothetical protein, with no established functional gene product[2][3]. Pseudogenes complicate genomic annotation and are sometimes misidentified as functional genes in high-throughput analyses[2][3]. They are virtually never considered canonical drug targets due to their lack of function[3]. In summary, ENSG00000228687 is not a conventional therapeutic target but a pseudogene, with no aliases, canonical molecular classification beyond "pseudogene," and no confirmed biological, disease, or pharmacological roles[2][3]. The name and description are problematic for drug discovery contexts, as the entity is nonfunctional and not suited for typical target-based approaches.

None (No pharmacological mechanisms; pseudogenes do not directly mediate cellular function as canonical receptors or enzymes do[3])